The Bio Investments Group is a Swiss-based company with a global presence, aiming to facilitate vaccines, in-vitro diagnostics, and biologics development and manufacturing in the global south nations. Their mission is to empower these nations to achieve self-reliance in manufacturing and supply assurance in less than 3 years. Through strategic global partnerships, the company delivers turnkey facilities capable of manufacturing vaccines and biologics in compliance with local regulatory requirements, as well as those of EMA and the US FDA.

The Bio Investments Group operates in multiple countries including Morocco, Oman, the UAE, Saudi Arabia, Egypt, USA, Nigeria, China, India, Australia, and Korea. Their areas of expertise include biopharmaceutical infrastructure development, technology and innovation transfer, and regulatory and compliance support. The company is committed to diversity and inclusion in their workforce, offering internships, graduate programs, and employee development to support their mission globally.

Contact them for collaboration inquiries or media inquiries